ESSA Pharma To Present At The 2024 Cantor Global Healthcare Conference

9/11/2024 4:16:24 PM

(MENAFN- PR Newswire) SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX ), a clinical-stage Pharmaceutical company focused on developing novel therapies for treatment of prostate cancer, today announced that the Company will be presenting at the 2024 Cantor Global Healthcare conference on Wednesday, September 18, 2024, at 9:10 a.m. ET in New York, NY.

David R. Parkinson, President and Chief Executive Officer, Peter Virsik, Chief Operating Officer and Executive Vice President, and David S. Wood, Chief financial Officer, will participate in a fireside chat.

A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at . Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit
, and follow us on
X
and
LinkedIn .

Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
[email protected]

Investors and Media:
Argot Partners
212.600.1902
[email protected]

SOURCE ESSA Pharma Inc

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN11092024003732001241ID1108663971

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.